Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor
February 03, 2022 09:00 ET
|
Nexien BioPharma, Inc.
DENVER, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Nexien BioPharma Inc. (OTCQB: NXEN) ("Nexien" or the "Company") today announced that it has retained Dr. Benedikt Schoser as an advisor to the Company. Dr....